What is MISTR?
MISTR operates as a specialized digital health platform dedicated to simplifying the acquisition of PrEP, a highly effective once-daily medication for HIV prevention. By integrating secure physician consultations with at-home laboratory testing, the company removes traditional barriers to entry in the healthcare system. MISTR further distinguishes itself by managing complex insurance documentation and providing complimentary medication delivery across the United States. This model not only enhances patient convenience but also addresses systemic inefficiencies in public health delivery, positioning the firm as a leader in accessible, patient-centric preventive medicine.
How much funding has MISTR raised?
MISTR has raised a total of $31K across 1 funding round:
Debt
$31K
Debt (2021): $31K with participation from PPP
Key Investors in MISTR
PPP
Public-Private Partnership
What's next for MISTR?
With the infusion of $31K, MISTR is well-positioned to scale its operations and broaden its reach within the United States. The company's strategic focus will likely center on enhancing its digital infrastructure to support a larger user base while maintaining the high standard of care required for sensitive medical services. As the firm matures through its Series B/C stage, the emphasis will shift toward optimizing supply chain logistics for medication delivery and potentially expanding its service portfolio to address broader sexual health needs. This capital deployment serves as a catalyst for long-term market penetration and operational excellence in the competitive telehealth arena.
See full MISTR company page
